The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis

被引：0
|
作者：
Ting Ding
Dan Tang
Mingrong Xi
机构：
[1] West China Second Hospital,Department of Obstetrics and Gynecology
[2] Key Laboratory of Birth Defects and Related Diseases of Women and Children,Department of Obstetrics and Gynecology
[3] Sichuan University,undefined
[4] Ministry of Education,undefined
[5] West China Second University Hospital,undefined
[6] Key Laboratory of Birth Defects and Related Diseases of Women and Children,undefined
[7] Sichuan University,undefined
[8] Ministry of Education,undefined
来源：
Journal of Ovarian Research | / 14卷
关键词：
Ovarian cancer; Secondary cytoreductive surgery; Meta-analysis; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The efficacy and safety of platinum-based chemotherapy for ovarian cancer in pregnancy: A protocol for systematic review and meta-analysis
    Wang, Bei
    Jia, Yiyi
    Liu, Liping
    MEDICINE, 2022, 101 (47) : E31954
  • [42] Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer
    Bijelic, L.
    Jonson, A.
    Sugarbaker, P. H.
    ANNALS OF ONCOLOGY, 2007, 18 (12) : 1943 - 1950
  • [43] Addition of bevacizumab to chemotherapy in patients with ovarian cancer: a systematic review and meta-analysis of randomized trials
    Li, J.
    Zhou, L.
    Chen, X.
    Ba, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (09) : 673 - 683
  • [44] The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis
    Chase, Dana M.
    Mahajan, Anadi
    Scott, David Alexander
    Hawkins, Neil
    Kalilani, Linda
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [45] The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis
    Dana M. Chase
    Anadi Mahajan
    David Alexander Scott
    Neil Hawkins
    Linda Kalilani
    BMC Women's Health, 24
  • [46] Chemotherapy for ovarian cancer during pregnancy: A systematic review and meta-analysis of case reports and series
    Jiang, Xingzhi
    Ye, Zhongxue
    Yu, Wen
    Fang, Qian
    Jiang, Yafen
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (10) : 3425 - 3436
  • [47] Addition of bevacizumab to chemotherapy in patients with ovarian cancer: a systematic review and meta-analysis of randomized trials
    J. Li
    L. Zhou
    X. Chen
    Y. Ba
    Clinical and Translational Oncology, 2015, 17 : 673 - 683
  • [48] Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis
    Zhang, Hongman
    Shen, Jie
    Yi, Lilan
    Zhang, Wei
    Luo, Peng
    Zhang, Jian
    JOURNAL OF CANCER, 2018, 9 (23): : 4556 - 4567
  • [49] Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis
    Bartels, Helena C.
    Rogers, Ailin C.
    Postle, James
    Shields, Conor
    Mulsow, Jurgen
    Conneely, John
    Brennan, Donal J.
    PLEURA AND PERITONEUM, 2019, 4 (02)
  • [50] Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases
    Fan, Xiao-Mei
    Zhang, Jun
    Niu, Shu-Huai
    Li, Kui-Xiu
    Song, Cang-Zhu
    INTERNATIONAL JOURNAL OF SURGERY, 2017, 38 : 61 - 66
12345